BioHorizons (BHZN) files plan for $100 million IPO
February 1, 2011 9:01 amBioHorizons (BHZN) has filed a plan for a $100 million IPO later this week. I like BioHorizons dental implants but that doesn’t make me want to buy the company. Dental implant pricing has become very price competitive and this will only further increase with the November 2010 combination of Sybron, a Danaher (DHR) company, with Dr. Gerald Niznick. Danaher is trading near its 52 week high for a good reason. BioHorizons also does not appear to offer a unique competitive advantage over dozens of competitors. This IPO does not interest me.
Tags: $100 million IPO initial public offering, BHZN, BioHorizons, Danaher, Niznick, SybronCategorised in: Dr. Dorfman Says
This post was written by Dr. Jeffrey Dorfman